Cargando…

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension

BACKGROUND: Headache is the dominant factor for quality of life related disability in idiopathic intracranial hypertension (IIH) and typically has migraine-like characteristics. There are currently no evidence-based therapeutics for headache in IIH, and consequently this is an important unmet clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiangou, Andreas, Mitchell, James L., Vijay, Vivek, Grech, Olivia, Bilton, Edward, Lavery, Gareth G., Fisher, Claire, Edwards, Julie, Mollan, Susan P., Sinclair, Alexandra J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523364/ https://www.ncbi.nlm.nih.gov/pubmed/32988380 http://dx.doi.org/10.1186/s10194-020-01182-7

Ejemplares similares

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Emerging themes in idiopathic intracranial hypertension
por: Grech, Olivia, et al.
Publicado: (2020)

Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)
por: Yiangou, Andreas, et al.
Publicado: (2021)

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
por: Grech, Olivia, et al.
Publicado: (2021)

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?
por: Yiangou, Andreas, et al.
Publicado: (2018)

Advances in the understanding of headache in idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2019)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension
por: Mitchell, James L, et al.
Publicado: (2022)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
por: Mitchell, James L., et al.
Publicado: (2019)

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema
por: Mollan, Susan P., et al.
Publicado: (2021)

European Headache Federation guideline on idiopathic intracranial hypertension
por: Hoffmann, Jan, et al.
Publicado: (2018)

Headache determines quality of life in idiopathic intracranial hypertension
por: Mulla, Yasmeen, et al.
Publicado: (2015)

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
por: Mitchell, James L, et al.
Publicado: (2023)

Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
por: Virdee, Jasvir, et al.
Publicado: (2020)

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial
por: Mollan, Susan P., et al.
Publicado: (2021)

Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study
por: Alimajstorovic, Zerin, et al.
Publicado: (2022)

Evaluation and management of adult idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2018)

Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom
por: Adderley, Nicola J., et al.
Publicado: (2019)

EHMTI-0304. Headache determines quality of life in idiopathic intracranial hypertension
por: Sinclair, A, et al.
Publicado: (2014)

Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system
por: Elliot, Laura, et al.
Publicado: (2021)

Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study
por: Adderley, Nicola Jaime, et al.
Publicado: (2022)

Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2022)

Alterations in metabolic flux in migraine and the translational relevance
por: Grech, Olivia, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide in Tension-Type Headache
por: Ashina, M.
Publicado: (2002)

Calcitonin Gene-Related Peptide in Tension-Type Headache
por: Ashina, Messoud
Publicado: (2001)

Calcitonin Gene-Related Peptide (CGRP) and Cluster Headache
por: Carmine Belin, Andrea, et al.
Publicado: (2020)

A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics
por: O’Reilly, Michael W., et al.
Publicado: (2019)

The expanding burden of idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2018)

The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes
por: Thaller, Mark, et al.
Publicado: (2022)

The Role of Metabolism in Migraine Pathophysiology and Susceptibility
por: Grech, Olivia, et al.
Publicado: (2021)

Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension
por: Aojula, Anuriti, et al.
Publicado: (2018)

Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
por: Scotton, William J, et al.
Publicado: (2018)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Multiple lumbar punctures aiming to relieve headache results in iatrogenic spinal hematoma: a case report
por: Lyons, Hannah S., et al.
Publicado: (2022)

The Influence of Calcitonin Gene-Related Peptide on Cerebral Hemodynamics in Nonmigraine Subjects with Calcitonin Gene-Related Peptide-Induced Headaches
por: Zupan, Matija, et al.
Publicado: (2021)

A Neuro-Ophthalmologist’s Guide to Advances in Intracranial Pressure Measurements
por: Mollan, Susan P, et al.
Publicado: (2023)

The Health Economic Evaluation of Bariatric Surgery Versus a Community Weight Management Intervention Analysis from the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)
por: Aguiar, Magda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ig2b8rupsqvujmg3jolisjphs0